Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety and Efficacy of Peficitinib in RA Extension Study
NCT01711814Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2012
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of peficitinib in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Started Sep 2012; status: completed.
02
Drugs
peficitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01711814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01711814.